EU Restricts Red Yeast Rice Supplements Over Safety Concerns
Executive Summary
Restrictions on daily doses and mandatory label warnings now apply to dietary supplements containing monacolins from red yeast rice sold in the EU following long-running safety concerns about the substance.
You may also be interested in...
ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension
A recent decision by the European Commission provides UK microbiome specialist ProBiotix Health with an opportunity to present its CholBiome extension as an alternative to red yeast rice as a way to “maintain normal blood cholesterol levels.”
Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient
Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.
Health Claim For Anxiety Reduction Among Latest EU Rejections
The health claim “Affron contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings” is one of four rejected by the European Commission in the first half of 2023.